Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Abstract

We observed significant placebo response which may be due to regression to the mean, response to a psychosocial intervention, natural course of symptoms, or nonspecific benefits of participation in a trial.